Breaks Categories: Stock Spotlights

FridayFeb 10, 2017 12:36 pm

NetworkNewsBreaks – Jaguar Animal Health, Inc. (NASDAQ: JAGX) Merger with Napo Pharmaceuticals Creates Significant Revenue Opportunities

In a move that captures synergistic and revenue-generating benefits, Jaguar Animal Health (NASDAQ: JAGX) is merging with San Francisco-based Napo Pharmaceuticals, Inc. The merger of the two companies is expected to provide Jaguar with a significant prescription revenue stream from sales of Mytesi™, which is FDA-approved for the symptomatic relief of noninfectious diarrhea in human adults with HIV/AIDS on antiretroviral therapy. The estimated U.S. market potential for Mytesti™, which launched in October 2016, is approximately $100 million in gross annual sales; the companies forecast the product will generate approximately $7.0 million in net sales in 2017. The active pharmaceutical ingredient…

Continue Reading

FridayFeb 10, 2017 11:50 am

NetworkNewsBreaks – ITUS Corp. (NASDAQ: ITUS) Shares Surge on Extended Record Date for $12M Stock Rights Offering

Shares of ITUS (NASDAQ: ITUS) are higher after the company changed the Record Date for its current stock rights offering of up to $12 million to March 1, 2017. New shareholders will need to purchase ITUS common stock by February 24, 2017. The company said it intends to use proceeds from the offering to reduce its debt and for general working capital purposes, including the continued development of Cchek™. "We are changing the Record Date due to the recent increased level of interest in ITUS and because we are presenting at 3 major investor conferences over the next two weeks…

Continue Reading

FridayFeb 10, 2017 11:11 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Recent Share Price Increase in Interview on MoneyTV

Full-service mobile technology and marketing provider SinglePoint, Inc. (OTC: SING) this morning was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” To view the show, visit www.MoneyTV.net. In this week’s episode, SinglePoint CEO Greg Lambrecht discusses the company’s recent milestones, including a sustained PPS increase. “First of all, we’re really pleased with the volume of the stock and the price increase that’s stayed there,” Lambrecht noted in the interview. “The second thing is, we really had three goals: to pay…

Continue Reading

FridayFeb 10, 2017 10:32 am

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) Continues Vertical Expansion, Meeting Industry Demand

National Waste Management Holdings, Inc. (OTC: NWMH) has converted its established line of services to address the need for construction and demolition (C&D) debris recycling. “With a strong dedication to Department of Environmental Protection standards and to the Sustainable Materials Management approach, National Waste Management Holdings focuses on reducing the volume of excessive waste by recycling several C&D materials. For this purpose, it has transformed its entire line of services to focus on recycling and has plans to set up a portable waste sorting line at its landfill this year, so as to increase recyclable rates. The company receives a…

Continue Reading

ThursdayFeb 09, 2017 11:44 am

NetworkNewsBreaks – Investors Applaud Marchex’s (NASDAQ: MCHX) Partnership with Facebook (NASDAQ: FB) to Launch Omnichannel Analytics Cloud; Shares Higher

Shares of Marchex (NASDAQ: MCHX) are up 16% after the mobile advertising analytics company announced its partnership with Facebook (NASDAQ: FB) that will integrate across its social analytics solution and into an industry-leading analytics platform called the Marchex Omnichannel Analytics Cloud. The integrated technology is designed to help marketers connect offline customer behavior to online marketing activity. “Online advertising has long struggled to connect digital engagements with accurate attribution to offline interactions and sales. While the influence of mobile phones and reach of digital channels like Facebook is undeniable, we also know that a large portion of sales are still…

Continue Reading

WednesdayFeb 08, 2017 12:05 pm

NetworkNewsBreaks – Cellect Biotechnology (NASDAQ: APOP) Treats First Cancer Patient In Phase I/II Trial of ApoGraft™; Shares Surge

Cellect Biotechnology (NASDAQ: APOP) is trading 26% higher mid-morning following word the company has treated the first blood cancer patient in the recently initiated phase I/II trial of its stem cell technology ApoGraft™. The intent of the trial is to assess the Cellect ApoGraft™ process which is designed to prevent Graft-versus-Host Disease (GvHD), a common complication linked to stem cell transplant. Additionally, the company expects to release definitive and complete results of its trial on healthy volunteers before the end of the first quarter this year. “Enrolling our first cancer patient to be treated using our groundbreaking method is a…

Continue Reading

TuesdayFeb 07, 2017 12:38 pm

NetworkNewsBreaks – Iao Kun Group Holding Company Ltd. (NASDAQ: IKGH) Enters Chinese Technology Industry with Majority Stake in LiNiu Network

Iao Kun Group (NASDAQ: IKGH) this morning said its strategy to focus on the Chinese technology industry begins with its acquisition of a 51% interest in Jia-Heng Industrial Ltd., the holding company of Guangzhou LiNiu Network Technology Co. Ltd., a software technology development company that's developing an electronic B2C trading platform focused on the Chinese agricultural industry. Per the agreement, IKGH will issue 12.484 million ordinary shares upon the transaction’s closing, as well as cash consideration that is contingent upon LiNiu Network achieving after-tax income targets. The acquisition is expected to close in the first quarter of 2017. “After appropriate…

Continue Reading

TuesdayFeb 07, 2017 12:36 pm

NetworkNewsBreaks – Israel’s B.O.S. (NASDAQ: BOSC) Hits “Significant Milestone” with $380,000 Order from American Customer

B.O.S. Better Online Solutions ("BOS") (NASDAQ: BOSC) is trading higher after the RFID and mobile solutions provider said its Supply Chain Division has received an electronic components order from an American customer valued at $380,000. The order is anticipated to be delivered in the first quarter of 2017. “This order marks a significant milestone in our sales to the American market, as we expect it to be followed by additional orders from this customer,” BOS president Avidan Zelicovski stated in the news release. BOS is scheduled to release its fourth-quarter and fiscal year results on March 21. To view the…

Continue Reading

TuesdayFeb 07, 2017 12:34 pm

NetworkNewsBreaks – VBI Vaccines, Inc. (NASDAQ: VBIV) Trades Higher on Positive Scientific Advice from EMA

VBI Vaccines (NASDAQ: VBIV) ("VBI") this morning said it has received positive scientific advice regarding its European development path for its Sci-B-Vac™ vaccine from the European Medical Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). In its letter, the CHMP stated its support of VBI's proposed plan to proceed to the phase III clinical studies of Sci-B-Vac™, and agreed that the product information and data from ongoing studies supports the phase III clinical studies and VBI's planned filing of a market authorization application. The company is also evaluating plans for the pivotal phase III clinical studies with the…

Continue Reading

MondayFeb 06, 2017 1:17 pm

NetworkNewsBreaks – Aytu Bioscience, Inc.’s (AYTU) MiOXSYS® Platform Addresses Diagnostic Challenges of Male Infertility

Oxidative stress is known to be a contributing factor to male infertility, though a significant amount of infertility cases remain unexplained. This is largely due to a lack of standardized tests to determine oxidative stress. A new clinical application called MiOXSYS®, however, is set to change that by assessing oxidative stress levels in semen as an aid in the diagnosis of male infertility. The platform is being developed by Aytu BioScience (OTCQX: AYTU), a leading pharmaceutical company focusing on the commercialization of innovative urology products. The company is currently pursuing regulatory approval for commercialization in the United States while boosting…

Continue Reading